Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Gallagher Kathleen P.. Insider active across 2 companies, notably Avidity Biosciences, Inc.. In total, 11 reports have been published. Split: 0 buy · 3 sells. Total volume traded: €67k. Activity tracked since 6 January 2025. The latest transaction was filed on 20 April 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations
Kathleen P. Gallagher is Chief Program Officer at Avidity Biosciences, Inc. She has 7 filings in total. In the 7 recent filings available, covering the period from 2025-01-08 to 2025-09-02, there were EUR 0 of buys and EUR 43,191 of sells, and the modal transaction nature is option exercise.